secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2026-07-07T14:38:16+00:00
Accession:  0001193125-26-297085
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Semnur signs binding term sheet for $100M strategic investment from iHolding Group at $10/share
--------------------------------------------------------------------------------

- iHolding to purchase $100M of newly issued common stock at $10/share (~10M shares).
- Proceeds to fund SEMDEXA Phase 3 program, product development, acquisitions, working capital.
- Investment subject to due diligence, definitive agreements, board/stockholder/regulatory approvals.
- Semnur is a majority-owned subsidiary of Scilex Holding Company.
- No assurance of consummation; risks of termination or litigation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000119312526297085/0001193125-26-297085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000119312526297085/smnr-20260703.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-297085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer